FLGT (STOCKS)
Fulgent Genetics, Inc. Common Stock
$15.300000
+0.870000 (+6.03%)
Prev close: $14.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Ming Hsieh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $477.67M
- Employees
- 1,313
- P/E (TTM)
- -7.78
- P/B (TTM)
- 0.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $322.67M |
| Benefits Costs and Expenses | $392.70M |
| Cost Of Revenue | $191.80M |
| Costs And Expenses | $392.70M |
| Gross Profit | $130.88M |
| Nonoperating Income/Loss | $21.07M |
| Operating Expenses | $221.97M |
| Research and Development | $53.91M |
| Other Operating Expenses | $168.07M |
| Operating Income/Loss | -$91.10M |
| Income/Loss From Continuing Operations After Tax | -$61.63M |
| Income/Loss From Continuing Operations Before Tax | -$70.03M |
| Income Tax Expense/Benefit | -$8.39M |
| Income Tax Expense/Benefit, Current | -$7.26M |
| Income Tax Expense/Benefit, Deferred | -$1.21M |
| Net Income/Loss | -$61.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.12M |
| Net Income/Loss Attributable To Parent | -$60.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$60.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 30,777,000 |
| Diluted Average Shares | 30,777,000 |
| Assets | $1.21B |
| Current Assets | $550.49M |
| Prepaid Expenses | $5.10M |
| Other Current Assets | $545.39M |
| Noncurrent Assets | $663.04M |
| Fixed Assets | $112.55M |
| Intangible Assets | $133.28M |
| Other Non-current Assets | $417.21M |
| Liabilities | $106.81M |
| Current Liabilities | $84.97M |
| Accounts Payable | $18.65M |
| Other Current Liabilities | $66.31M |
| Noncurrent Liabilities | $21.84M |
| Equity | $1.11B |
| Equity Attributable To Noncontrolling Interest | -$5.27M |
| Equity Attributable To Parent | $1.11B |
| Liabilities And Equity | $1.21B |
| Net Cash Flow From Operating Activities | -$101.64M |
| Net Cash Flow From Operating Activities, Continuing | -$101.64M |
| Net Cash Flow From Investing Activities | $111.37M |
| Net Cash Flow From Investing Activities, Continuing | $111.37M |
| Net Cash Flow From Financing Activities | -$14.79M |
| Net Cash Flow From Financing Activities, Continuing | -$14.79M |
| Exchange Gains/Losses | $105.00K |
| Net Cash Flow | -$4.95M |
| Net Cash Flow, Continuing | -$5.06M |
| Comprehensive Income/Loss | -$53.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$1.21M |
| Comprehensive Income/Loss Attributable To Parent | -$52.63M |
| Other Comprehensive Income/Loss | $7.79M |